Articles by Gordon R. Bernard

1 2 3 4 5

Atypical Sleep in Ventilated Patients: Empirical Electroencephalography Findings and the Path Toward Revised ICU Sleep Scoring Criteria.

Watson, Paula L.; Pandharipande, Pratik; Gehlbach, Brian K.; More

Critical Care Medicine. ., Post Author Corrections: June 12, 2013

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Rhodes, Andrew; Evans, Laura E.; Alhazzani, Waleed; More

Critical Care Medicine. 45(3):486-552, March 2017.

  • Editor's Choice

Impact of Initial Central Venous Pressure on Outcomes of Conservative Versus Liberal Fluid Management in Acute Respiratory Distress Syndrome

Semler, Matthew W.; Wheeler, Arthur P.; Thompson, B. Taylor; More

Critical Care Medicine. 44(4):782-789, April 2016.

Randomized, Placebo-Controlled Trial of Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis: The Acetaminophen for the Reduction of Oxidative Injury in Severe...

Janz, David R.; Bastarache, Julie A.; Rice, Todd W.; More

Critical Care Medicine. 43(3):534-541, March 2015.

Statins and Delirium During Critical Illness: A Multicenter, Prospective Cohort Study*

Morandi, Alessandro; Hughes, Christopher G.; Thompson, Jennifer L.; More

Critical Care Medicine. 42(8):1899-1909, August 2014.

Evaluating the Efficacy and Safety of Two Doses of the Polyclonal Anti-Tumor Necrosis Factor-α Fragment Antibody AZD9773 in Adult Patients With Severe Sepsis and/or Septic Shock: ...

Bernard, Gordon R.; Francois, Bruno; Mira, Jean-Paul; More

Critical Care Medicine. 42(3):504-511, March 2014.

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis...

Vincent, Jean-Louis; Ramesh, Mayakonda K.; Ernest, David; More

Critical Care Medicine. 41(9):2069-2079, September 2013.

Atypical Sleep in Ventilated Patients: Empirical Electroencephalography Findings and the Path Toward Revised ICU Sleep Scoring Criteria

Watson, Paula L.; Pandharipande, Pratik; Gehlbach, Brian K.; More

Critical Care Medicine. 41(8):1958-1967, August 2013.

Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*

Hooper, Michael H.; Weavind, Lisa; Wheeler, Arthur P.; More

Critical Care Medicine. 40(7):2096-2101, July 2012.

Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial*

Girard, Timothy D.; Pandharipande, Pratik P.; Carson, Shannon S.; More

Critical Care Medicine. 38(2):428-437, February 2010.

Derivation and validation of Spo2/Fio2 ratio to impute for Pao2/Fio2 ratio in the respiratory component of the Sequential Organ Failure Assessment score*

Pandharipande, Pratik P.; Shintani, Ayumi K.; Hagerman, Heather E.; More

Critical Care Medicine. 37(4):1317-1321, April 2009.

Delirium and sedation in the intensive care unit: Survey of behaviors and attitudes of 1384 healthcare professionals*

Patel, Rina P.; Gambrell, Meredith; Speroff, Theodore; More

Critical Care Medicine. 37(3):825-832, March 2009.

A replicable method for blood glucose control in critically Ill patients

Morris, Alan H.; Orme, James Jr; Truwit, Jonathon D.; More

Critical Care Medicine. 36(6):1787-1795, June 2008.

A double-blind placebo-controlled study to evaluate the safety and efficacy of L-2-oxothiazolidine-4-carboxylic acid in the treatment of patients with acute respiratory distress...

Morris, Peter E.; Papadakos, Peter; Russell, James A.; More

Critical Care Medicine. 36(3):782-788, March 2008.

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

Vincent, Jean-Louis; Bernard, Gordon R.; Beale, Richard; More

Critical Care Medicine. 33(10):2266-2277, October 2005.

Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*

Parsons, Polly E.; Eisner, Mark D.; Thompson, B Taylor; More

Critical Care Medicine. 33(1):1-6, January 2005.

Sources of variability on the estimate of treatment effect in the PROWESS trial: Implications for the design and conduct of future studies in severe sepsis*

Macias, William L.; Vallet, Benoit; Bernard, Gordon R.; More

Critical Care Medicine. 32(12):2385-2391, December 2004.

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial*

Vincent, Jean-Louis; Angus, Derek C.; Artigas, Antonio; More

Critical Care Medicine. 31(3):834-840, March 2003.

Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis

Ely, E. Wesley; Laterre, Pierre-François; Angus, Derek C.; More

Critical Care Medicine. 31(1):12-19, January 2003.

Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis

Bernard, Gordon R.; Ely, E. Wesley; Wright, Theressa J.; More

Critical Care Medicine. 29(11):2051-2059, November 2001.

Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis

Mangialardi, Robert J.; Martin, Greg S.; Bernard, Gordon R.; More

Critical Care Medicine. 28(9):3137-3145, September 2000.

1 2 3 4 5